Pandey, Rajesh <br/><br/>
Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  Dec 2003 
 - 981-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0305-7453 
<br/><br/><label>Standard No.: </label>10.1093/jac/dkg477  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Aerosols<br/>Animals<br/>Antibiotics, Antitubercular--administration & dosage<br/>Antitubercular Agents--administration & dosage<br/>Area Under Curve<br/>Biological Availability<br/>Chemical Phenomena<br/>Chemical and Drug Induced Liver Injury--pathology<br/>Chemistry, Physical<br/>Colony Count, Microbial<br/>Drug Carriers<br/>Drug Combinations<br/>Drug Compounding<br/>Female<br/>Guinea Pigs<br/>Half-Life<br/>Injections, Intravenous<br/>Isoniazid--administration & dosage<br/>Lactic Acid<br/>Lung--metabolism<br/>Male<br/>Microspheres<br/>Mycobacterium tuberculosis--drug effects<br/>Particle Size<br/>Polyglycolic Acid<br/>Polylactic Acid-Polyglycolic Acid Copolymer<br/>Polymers<br/>Pyrazinamide--administration & dosage<br/>Rifampin--administration & dosage<br/>Tuberculosis--drug therapy